Ashley Gallagher, Associate Editor

When the mRNA was removed, these remained in the cell for a long time and were able to maintain their function, new study results show.

Mathematical model from Penn State shows an alternative to business shutdowns and stay-at-home orders that are unsustainable over time.

Lindsay Bealor Greenleaf, MBA, JD, Vice President of ADVI Health, discusses a new poll from the Kaiser Family Foundation that found that 83% of Americans believe the government should be allowed to negotiate lower drug prices, for both those on Medicare and in private insurance plans.

Mark Garofoli, director of Experiential Learning Program at WVU School of Pharmacy, discusses his CPhT 2021 conference presentation regarding the role and impact of pharmacy technicians on opioids in the pharmacy.

Linda Mendonça, DNP, RN, PHNA-BC, president of the National Association of School Nurses, discusses a new poll released by the COVID-19 Vaccine Education and Equity Project and the National Association of School Nurses about parents’ plans to vaccinate their school-aged children.

Study indicates that women with trauma had greater white matter hyperintensities (WMH) than women without trauma, and the most common trauma associated with WMH was sexual violence.

Investigators reviewed 65 analyses published in the Journal of Affective Disorders showing that by mid-2020 signs were comparable to pre-COVID-19 levels.

Emily Holcomb, PharmD, BCPS, ISMP Safe Medication Management Fellow, discusses her CPhT 2021 conference presentation regarding targeted medication safety best practices.

Individuals who are insulin-resistant are 2.66 times more likely to suffer from major depression than those who are not insulin-resistant.

Those aged 18 to 34 years self-treat with cannabidiol or cannabis at 2 times the rate of people aged 45 years or older.

The phase 2 Elara trial for the follicular lymphoma treatment met its primary endpoints, Novartis says.

J&J study results show that ustekinumab was beneficial in treating adults with the 2 types of IBD.

ARTISTRY-7 will analyze the anti-tumor activity and safety of the combination compared with chemotherapy for individuals with platinum-resistant ovarian cancer.

Investigators conclude that minimal residual disease cells, or those that survive the initial treatment, may carry some form of epigenetic and metabolic memory of the tumor.

Paula Durlofsky, PhD, a writer for the American Psychological Association's Device Management and Digital Intelligence committee discusses how social media has impacted the mental health of health care professionals in recent years, including the COVID-19 Pandemic.

The rate of distant metastasis at 10 years was 29% for individuals whose scores demonstrated more aggressive disease compared with 13% for those who showed lower risk.

Walgreens Boots Alliance announces new mental health services including mental health first aid training, Walgreens Find Care, and more partnerships for other mental health resources.

Amy Summers, PharmD, BCSCP, consultant at Restore Health Consulting, discusses her CPhT 2021 conference presentation regarding proposed changes to the USP <795> and <797>.

There is a survival advantage for those who were also treated with surgery, according to new study results.

Phase 3 ILLUMINATE showed the percentage of individuals with HIV-1 RNA levels ≥50 copies/mL for the once-a-day combination pill of doravirine/islatravir.

The drug previously received approval to treat mucosal melanoma but could be used in combination with pembrolizumab.

The immune response of all 15 serotypes in the V114 pneumococcal vaccination were higher than those in the PCV13 vaccination.

A study finds that intravenous immunoglobulin therapy is a beneficial way to combat parvovirus-induced PRCA in individuals with anemia.

The CDC recommends booster doses of Moderna’s COVID-19 vaccine and Johnson & Johnson’s single-shot COVID-19 vaccine for eligible individuals.

After switching to Biktarvy, 91% of patients remained virologically suppressed at week 24 in a cohort study.

Celecoxib and tramadol hydrochloride (Seglentis; Esteve Pharmaceuticals) is an oral prescription with a unique co-crystal formulation of the anti-inflammatory drug, celecoxib, and the schedule IV opioid analgesic drug, tramadol.

Study results show that annual screening can identify cases of prostate cancer up to 8 times as often in those with hereditary Lynch syndrome than in those who do not get the tests.

Taking all 3 doses also helped patients experience higher A1C levels than patients who took titrated insulin glargine, clinical trial results show.

New study results show that single-dose vaccination may benefit populations with limited supplies.

Study results shows that patients who have been diagnosed with the disease may face many challenges, which can increase anxiety or depression.